Medicare Part

Providers in DC, DE, MD, NJ & PA

JL Home

►

Outreach and Education

►

Provider specialty: COVID-19 vaccine and monoclonal antibodies

Provider specialty: COVID-19 vaccine, monoclonal antibodies, and treatments

This is a central location for all COVID-19 vaccine billing, monoclonal antibody infusion, and treatment information, including links to related CMS resources and references.

These services include information on the COVID-19 vaccine, monoclonal antibodies, treatments, and their administration.

General information regarding the Medicare program overall can be found using the topics down your left navigation bar. Please subscribe to our mailing lists to stay current with Medicare.

Billing and coding

Billing COVID-19 convalescent plasma in outpatient setting

Billing for COVID-19 vaccine home administration

Billing VEKLURY (remdesivir) antiviral medication in outpatient settings

Coding for COVID-19 vaccine shots

COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) billing

COVID-19 vaccine and monoclonal antibodies billing for Part A

COVID-19 vaccine and monoclonal antibodies billing for Part B

COVID-19 vaccine and monoclonal antibody (mAb) infusion FAQs

COVID-19 vaccine and monoclonal antibody (mAb) infusion billing alerts

COVID-19 provider toolkit

Enforcement Discretion Notice Relating to Certain Pharmacy Billing

Indian Health Services COVID-19 vaccine and monoclonal antibody (mAb) infusion administration

Medicare Enrolled Ambulance Suppliers Administering the COVID-19 Vaccine

Monoclonal antibody COVID-19 infusion

Medicare billing for COVID-19 vaccine shot administration

SNF: Enforcement discretion relating to certain pharmacy billing

Mass immunizers and roster billers

PC-ACE user guide: Section 5 flu, pneumonia, or COVID-19 injection roster billing

Centralized billing for vaccines

COVID-19 vaccines or monoclonal antibody infusion roster form

EDI centralized mass immunizer packet

Roster billing for Part A providers

Roster billing for Part B providers

Roster billing for mass immunizers

Reimbursement

COVID-19 vaccines and monoclonal antibodies

COVID-19 vaccines:

COVID-19 vaccine reimbursement 2020 | 2021 | 2022 | 2023

COVID-19 vaccine administration fees for centralized billers, Indian Health Services, and Veterans Affairs 2020 | 2021 | 2022 | 2023

2020 geographically-adjusted payment rates for COVID-19 vaccine administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP)

Jan - March 2021 geographically-adjusted payment rates for COVID-19 vaccine administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) *Updated February 16, 2021, for addition of the COVID-19 Janssen vaccine* (For claims with dates of service of 1/1/2021 through 3/14/2021)

March - Dec 2021 geographically-adjusted payment rates for COVID-19 vaccine administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) Updated 8/12/2021 to account for new codes describing the administration of the third dose of the Pfizer and Moderna vaccines (For claims with dates of service 3/15/2021 – 12/31/2021)

Jan - Dec 2022 geographically-adjusted payment rates for COVID-19 vaccine administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) Updated 12/20/2022 to reflect the new codes for Moderna and Pfizer-BioNTech pediatric bivalent (updated COVID-19 vaccines) booster dose/ third dose (For claims with dates of service 12/08/2022 through 12/31/2022)

Jan - Dec 2023 Geographically-adjusted payment rates for COVID-19 vaccine administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) (For claims with dates of service 01/01/2023 through 12/31/2023)

Medicare COVID-19 vaccine shot payment

Monoclonal antibodies:

COVID-19 monoclonal antibodies reimbursement 2020 | 2021 | 2022 | 2023

COVID-19 monoclonal antibodies administration (mAb) for centralized billers, Indian Health Services, and Veterans Affairs 2020 | 2021 | 2022 | 2023

Jan - May 2021 geographically adjusted payment rates for monoclonal antibody administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) (For claims with dates of service of 1/1/2021 through 5/5/2021)

May - Dec 2021 geographically adjusted payment rates for monoclonal antibody administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) *Updated 12/23/2021 to account for new codes for tixagevimab co-packaged with cilgavimab* (For claims with dates of service 5/6/2021 through 12/31/2021)

Jan - Dec 2022 geographically-adjusted payment rates for monoclonal antibody administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) *Updated 02/17/2022 to reflect the new codes for bebtelovimab (For claims with dates of service 02/11/2022 through 12/31/2022)

Jan-Dec 2023 Geographically-adjusted payment rates for monoclonal antibody administration (for providers & suppliers paid MPFS-adjusted rates) (ZIP) (For claims with dates of services 01/01/2023 through 12/31/2023)